Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza

Immunology

Volumn 132, Issue 4, 2011, Pages 516-526

  Jost, Stephanie ^a   Reardon, Jeff ^a   Peterson, Eric ^a   Poole, Danielle ^a   Bosch, Ronald ^b   Alter, Galit ^a   Altfeld, Marcus ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

Author keywords

2B4; Influenza; Innate immunity; Natural killer cells; NKp46

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; LYMPHOCYTE RECEPTOR; LYMPHOCYTE RECEPTOR 2B4; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VACCINATION; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ADULT; ANTIGENS, CD; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RECEPTORS, IMMUNOLOGIC; VACCINATION; YOUNG ADULT;

EID: 79952501571     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03394.x     Document Type: Article

References (53)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
2. Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, Meltzer MI, Bresee JS, Shay DK. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses 2009; 3:37-49.
3. + T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 1997; 159:105-17.
4. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006; 12:48-54.
5. Achdout H, Arnon TI, Markel G et al. Enhanced recognition of human NK receptors after influenza virus infection. J Immunol 2003; 171:915-23.
6. Achdout H, Manaster I, Mandelboim O. Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J Virol 2008; 82:8030-7.
7. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 2008; 118:1017-26.
8. Arnon TI, Achdout H, Lieberman N et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 2004; 103:664-72.
9. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 2001; 31:2680-9.
10. Draghi M, Pashine A, Sanjanwala B et al. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 2007; 178:2688-98.
11. Gazit R, Gruda R, Elboim M et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006; 7:517-23.
12. Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 2004; 172:5598-605.
13. Kos FJ, Engleman EG. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol 1996; 173:1-6.
14. Mandelboim O, Lieberman N, Lev M et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409:1055-60.
15. Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 2008; 129:223-30.
16. Owen RE, Yamada E, Thompson CI et al. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J Virol 2007; 81:11170-8.
17. Siren J, Sareneva T, Pirhonen J, Strengell M, Veckman V, Julkunen I, Matikainen S. Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages. J Gen Virol 2004; 85:2357-64.
18. Stein-Streilein J, Guffee J. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J Immunol 1986; 136:1435-41.
19. Stein-Streilein J, Guffee J, Fan W. Locally and systemically derived natural killer cells participate in defense against intranasally inoculated influenza virus. Reg Immunol 1988; 1:100-5.
20. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol 2004; 25:47-52.
21. Ennis FA, Meager A, Beare AS, Qi YH, Riley D, Schwarz G, Schild GC, Rook AH. Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet 1981; 2:891-3.
22. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. The trafficking of natural killer cells. Immunol Rev 2007; 220:169-82.
23. Reynolds CW, Timonen T, Herberman RB. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol 1981; 127:282-7.
24. Stein-Streilein J, Bennett M, Mann D, Kumar V. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J Immunol 1983; 131:2699-704.
25. Dong L, Mori I, Hossain MJ, Kimura Y. The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis 2000; 182:391-6.
26. Liu B, Mori I, Hossain MJ, Dong L, Takeda K, Kimura Y. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 2004; 85:423-8.
27. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993; 151:60-70.
28. Nakajima H, Cella M, Langen H, Friedlein A, Colonna M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 1999; 29:1676-83.
29. Schuhmachers G, Ariizumi K, Mathew PA, Bennett M, Kumar V, Takashima A. 2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors. J Invest Dermatol 1995; 105:592-6.
30. Valiante NM, Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993; 178:1397-406.
31. Assarsson E, Kambayashi T, Persson CM, Chambers BJ, Ljunggren HG. 2B4/CD48-mediated regulation of lymphocyte activation and function. J Immunol 2005; 175:2045-9.
32. Bryceson YT, Ljunggren HG, Long EO. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009; 114:2657-66.
33. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006; 107:159-66.
34. Sivori S, Parolini S, Falco M, Marcenaro E, Biassoni R, Bottino C, Moretta L, Moretta A. 2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol 2000; 30:787-93.
35. Chuang SS, Kim MH, Johnson LA, Albertsson P, Kitson RP, Nannmark U, Goldfarb RH, Mathew PA. 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology 2000; 100:378-83.
36. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev 2008; 8:259-68.
37. Mathew SO, Vaidya SV, Kim JR, Mathew PA. Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element. Biochem Biophys Res Commun 2007; 355:483-7.
38. Sandusky MM, Messmer B, Watzl C. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation. Eur J Immunol 2006; 36:3268-76.
39. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294:15-22.
40. Alter G, Teigen N, Davis BT et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005; 106:3366-9.
41. He XS, Draghi M, Mahmood K et al. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest 2004; 114:1812-9.
42. Boles KS, Nakajima H, Colonna M, Chuang SS, Stepp SE, Bennett M, Kumar V, Mathew PA. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens 1999; 54:27-34.
43. Mathew PA, Garni-Wagner BA, Land K, Takashima A, Stoneman E, Bennett M, Kumar V. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol 1993; 151:5328-37.
44. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998; 188:2083-90.
45. Latchman Y, McKay PF, Reiser H. Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol 1998; 161:5809-12.
46. Bender A, Amann U, Jager R, Nain M, Gemsa D. Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity. J Immunol 1993; 151:5416-24.
47. Fesq H, Bacher M, Nain M, Gemsa D. Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology 1994; 190:175-82.
48. Nain M, Hinder F, Gong JH, Schmidt A, Bender A, Sprenger H, Gemsa D. Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol 1990; 145:1921-8.
49. Du N, Zhou J, Lin X, Zhang Y, Yang X, Wang Y, Shu Y. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol 2010; 84: 7822-31.
50. Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y, Malarkannan S. The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol 2009; 87:579-89.
51. Mao H, Tu W, Qin G et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol 2009; 83:9215-22.
52. Chlewicki LK, Velikovsky CA, Balakrishnan V, Mariuzza RA, Kumar V. Molecular basis of the dual functions of 2B4 (CD244). J Immunol 2008; 180:8159-67.
53. Long BR, Michaelsson J, Loo CP et al. Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin Vaccine Immunol 2008; 15:120-30.